Responses
Clinical and epidemiological research
Extended report
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study
Compose a Response to This Article
Other responses
No responses have been published for this article.